Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information


helen.campbell@dph.ox.ac.uk


+44 (0)1865 289274

Publications In Press 

                                         
Costs and quality of life associated with acute upper gastrointestinal bleeding in the UK: cohort analysis of patients in a cluster randomised trial         

Campbell HE et al, BMJ Open                                   

                                    
 A multi-centre randomised controlled trial of Transfusion Indication Threshold Reduction on transfusion rates, morbidity and healthcare resource use following cardiac surgery (TITRe2)  

Reeves BC et al, Health Technology Assessment                            

       
   
                                   

 

                               

                    

       
   
                                   

                               

 

Helen Campbell

BA MSc DPhil

Senior Researcher (MRC Special Training Fellow)

Helen Campbell joined the Health Economic Research Centre in September 2002, having previously worked at Brunel University and prior to this completing her MSc in Health Economics at York University in 1998.  Helen is currently working on a number of projects, which include an economic evaluation of follow-up regimes for patients who have undergone resection for colorectal cancer, a five year programme of work on the health economics of massive blood transfusion in trauma patients, and a trial based economic evaluation of total versus partial knee arthroplasty.  In 2004, Helen took up a Special Training Fellowship in Health Services Research from the UK Medical Research Council.  In 2008 she successfully completed a DPhil at the University of Oxford on the cost-effectiveness of using prognostic information to select women with early breast cancer for adjuvant systemic therapy.